Salipro Biotech et Boehringer Ingelheim concluent un accord de recherche et de licence en vue d’accélérer plusieurs programmes du pipeline de Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, 13 mars 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, société suédoise de biotechnologie spécialisée dans la stabilisation de cibles pharmacologiques difficiles à étudier, a annoncé ce...
Salipro Biotech und Boehringer Ingelheim schließen Forschungs- und Lizenzvertrag zur Beschleunigung mehrerer Pipeline-Programme von Boehringer Ingelheim
13 mars 2025 09h00 HE
|
Salipro Biotech AB
STOCKHOLM, March 13, 2025 (GLOBE NEWSWIRE) -- Salipro Biotech AB, ein schwedisches Biotechnologieunternehmen, das sich auf die Stabilisierung anspruchsvoller Wirkstoffziele spezialisiert hat, gab...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
13 mars 2025 09h00 HE
|
Salipro Biotech AB
Salipro Biotech and Boehringer Ingelheim enter research and license agreement to accelerate multiple Boehringer Ingelheim pipeline programs.
Pharmacovigilance Market Forecast to Surge to $24.76 Billion by 2030, Creating Lucrative Opportunities for Digital Transformation in Drug Safety
13 mars 2025 07h43 HE
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Market by Type (Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting), Product Life Cycle (Phase I, Phase II, Phase III),...
Trump-era and JFK Jr Administration Drug Development & Outsourcing Impact Report 2025 Featuring IQVIA, Catalent, WuXi, Charles River, Fortrea, ICON, Lonza, Parexel, Syneos Health, Thermo Fisher
13 mars 2025 06h15 HE
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Trump-era Administration Drug Development & Outsourcing Impact Report 2025" report has been added to ResearchAndMarkets.com's offering. This...
Pattern Unveils Adaptive Example Selection™ (AES™) Framework to Revolutionize Medical AI Interpretability
12 mars 2025 08h30 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., March 12, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), a leader in cutting-edge explainable AI (XAI) research, has introduced a transformative new...
Generative AI in Drug Discovery and Development Process Course: FDA Embraces Generative AI to Propel Drug Discovery and Development Forward (ONLINE EVENT: April 2, 2025 & ON-DEMAND)
10 mars 2025 08h30 HE
|
Research and Markets
Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Drug Discovery" training has been added to ResearchAndMarkets.com's offering. The US FDA's encouragement of AI technology in...
Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline
07 mars 2025 08h00 HE
|
MindRank
HANGZHOU, China and LONDON, March 07, 2025 (GLOBE NEWSWIRE) -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announces today that the U.S. Food and Drug...
Common Technical Document Course: Regulatory and Technical requirements for CMC Management of Your Full and Generic Application in Major Markets of the EU and USA (ONLINE EVENT: March 11-12, 2025)
24 févr. 2025 05h23 HE
|
Research and Markets
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "The Common Technical Document Training Course" conference has been added to ResearchAndMarkets.com's offering. This interactive two-day course will...
AI in Pharmacovigilance Training Course: Transformative Impacts on Drug Safety and Monitoring (ONLINE EVENT: March 12, 2025/ON-DEMAND)
24 févr. 2025 04h56 HE
|
Research and Markets
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "AI in Pharmacovigilance Training Course" has been added to ResearchAndMarkets.com's offering. This course will provide a comprehensive introduction...